Krüppel-Like Factor 2 Is a Gastric Cancer Suppressor and Prognostic Biomarker

Figure 3

CNV analysis of the KLF2 gene in GC and its effect on overall survival (GSCA). (a) Proportion of KLF2 heterozygous/homozygous and amplified/deleted in STAD. (b) Spearman correlation assessment of CNV and KLF2 mRNA expression in STAD. (c) Survival difference between KLF2 CNV and wild type in STAD patients.

(a)

(b)

(c)